Business Standard

Lessons from Covid: Pharma firms turn attention to adult vaccination

Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well

vaccine
Premium

Companies are, in fact, creating new teams as their focus on adult vaccination increases

Sohini Das Mumbai
The Covid-19 pandemic led to the world’s largest adult vaccination campaign, with more than 13 billion doses administered globally, so far. Around 2.5 million doses of Covid-19 vaccines are being administered daily now across the world. Vaccine companies have thus warmed up to the idea of adult vaccination against non-Covid infections, as well  — pneumonia, flu, and shingles, to name a few.
 
According to Pfizer India country president S Sridhar: “While India’s largest vaccination programme for Covid-19 demonstrated utility, acc¬ep¬tance, and system readiness for adult immu¬nisation, a lot more needs to be done. Therefore, Pfizer has been a frontrunner to

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 04 2022 | 5:56 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com